Table 3.
Outcome data at all measuring points and within-group effect sizes.
| Treatment completer sample (n = 40) | Intent-to-treat sample (n = 58) | |||
|---|---|---|---|---|
| NET (n = 25) | DBT-bt (n = 16) | NET (n = 29) | DBT-bt (n = 25) | |
| CAPS | ||||
| Pre-treatment (M, SD) | 78.50 (12.02) | 76.94 (15.68) | 77.59 (11.60) | 77.74 (17.36) |
| Post-treatment (M, SD) | 55.18 (24.43) | 54.87 (15.78) | 54.40 (23.67) | 56.58 (15.63) |
| 12-months follow-up (M, SD) | 56.24 (31.06) | 61.68 (20.67) | 58.40 (32.26) | 60.54 (23.58) |
| Hedges' g (pre-post) | 1.2 | 1.4 | 1.3 | 1.3 |
| Hedges' g (pre-FU) | 1.0 | 0.8 | 0.8 | 0.8 |
| PDS | ||||
| Pre-treatment (M, SD) | 34.31 (6.69) | 34.70 (10.24) | 34.88 (7.00) | 35.49 (10.16) |
| Post-treatment (M, SD) | 27.88 (11.26) | 27.45 (10.72) | 26.78 (11.68) | 28.65 (10.79) |
| 12-months follow-up (M, SD) | 23.69 (12.70) | 27.10 (10.41) | 24.10 (12.93) | 26.92 (10.36) |
| Hedges' g (pre-post) | 0.7 | 0.7 | 0.9 | 0.7 |
| Hedges' g (pre-FU) | 1.1 | 0.7 | 1.1 | 0.8 |
| SCID-II-BPD | ||||
| Pre-treatment (M, SD) | 6.96 (1.23) | 6.75 (1.24) | 7.03 (1.27) | 6.90 (1.35) |
| Post-treatment (M, SD) | – | – | – | – |
| 12-months follow-up (M, SD) | 4.76 (2.72) | 4.31 (2.27) | 4.80 (2.67) | 4.41 (2.13) |
| Hedges' g (pre-FU) | 1.1 | 1.3 | 1.1 | 1.4 |
| BSL | ||||
| Pre-treatment (M, SD) | 2.08 (0.69) | 2.35 (0.44) | 2.13 (0.69) | 2.30 (0.52) |
| Post-treatment (M, SD) | 1.62 (0.72) | 1.50 (0.59) | 1.57 (0.73) | 1.63 (0.68) |
| 12-months follow-up (M, SD) | 1.61 (0.82) | 1.71 (0.70) | 1.62 (0.84) | 1.62 (0.80) |
| Hedges' g (pre-post) | 0.7 | 1.6 | 0.8 | 1.1 |
| Hedges' g (pre-FU) | 0.6 | 1.1 | 0.7 | 1.0 |
| BDI-II | ||||
| Pre-treatment (M, SD) | 36.76 (9.44) | 43.31 (6.22) | 36.65 (9.00) | 43.19 (6.15) |
| Post-treatment (M, SD) | 25.75 (12.85) | 25.95 (12.74) | 25.31 (12.47) | 27.70 (12.95) |
| 12-months follow-up (M, SD) | 24.88 (15.52) | 31.17 (12.14) | 25.47 (15.06) | 30.17 (12.75) |
| Hedges' g (pre-post) | 1.1 | 1.7 | 1.2 | 1.6 |
| Hedges' g (pre-FU) | 1.1 | 1.3 | 1.1 | 1.3 |
| DES | ||||
| Pre-treatment (M, SD) | 30.39 (17.41) | 35.34 (18.01) | 31.27 (17.42) | 27.38 (20.60) |
| Post-treatment (M, SD) | 25.07 (15.75) | 24.94 (14.92) | 24.48 (15.47) | 26.77 (14.47) |
| 12-months follow-up (M, SD) | 19.62 (14.07) | 24.00 (18.00) | 21.61 (17.79) | 22.21 (17.07) |
| Hedges' g (pre-post) | 0.3 | 0.6 | 0.4 | 0.3 |
| Hedges' g (pre-FU) | 0.7 | 0.6 | 0.5 | 0.6 |
| SCL-90-R | ||||
| Pre-treatment (M, SD) | 1.92 (0.55) | 2.19 (0.59) | 1.94 (0.57) | 2.08 (0.60) |
| Post-treatment (M, SD) | 1.39 (0.72) | 1.55 (0.64) | 1.35 (0.72) | 1.62 (0.62) |
| 12-months follow-up (M, SD) | 1.49 (0.74) | 1.73 (0.68) | 1.50 (0.78) | 1.57 (0.75) |
| Hedges' g (pre-post) | 0.8 | 1.0 | 0.9 | 0.8 |
| Hedges' g (pre-FU) | 0.7 | 0.7 | 0.7 | 0.8 |
| WHOQOL—Global score | ||||
| Pre-treatment (M, SD) | 30.68 (18.39) | 28.90 (11.83) | 31.50 (18.44) | 25.00 (13.36) |
| Post-treatment (M, SD) | 36.98 (18.97) | 41.40 (19.75) | 38.46 (19.66) | 38.82 (19.50) |
| 12-months follow-up (M, SD) | 37.50 (21.41) | 38.33 (21.37) | 40.00 (20.92) | 40.00 (20.92) |
| Hedges' g (pre-post) | -0.3 | -0.7 | -0.4 | -0.8 |
| Hedges' g (pre-FU) | -0.3 | -0.6 | -0.4 | -0.9 |
NET, Narrative Exposure Therapy; DBT-bt, Dialectical Behavior Therapy; CAPS, Clinician Administered PTSD Scale (Blake, 2000; PDS, Posttraumatic Stress Diagnostic Scale; SCID-II, Structured Clinical Interview for DSM-IV, Personality Disorders; BPD, Borderline Personality Disorder; BSL, Borderline Symptom List; BDI-II, Beck Depression Inventory Revision; DES, Dissociative Experience Scale; SCL-90-R, Symptom Checklist 90 Items Revised Version; WHOQOL, World Health Organization Quality of Life (higher values indicate more quality of life). For information on significant differences between groups and across time points, see text *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.